Table 1.

Data on breast-cancer patient-derived xenograft (PDX), including tumor diagnosis, grade, sex, age, race, and expression information of ER (estrogen receptor), PR (progesterone receptor), HER2, ROR1, cortactin, or Wnt5a. Here, “yes” means “expressed”, and “no” means “not expressed”

PDX samples	Diagnosis	Grade	Sex	Age	Race	ER	PR	HER2	ROR1	Cortactin	Wnt5a
1	Invasive ductal carcinoma	Grade 3	Female	73	White	No	No	Yes	No	Yes	Yes
2	Invasive ductal carcinoma	Grade 3	Female	64	White	No	No	No	No	Yes	Yes
3	Mixed ductal carcinoma	Grade 3	Female	52	White	No	No	No	Yes	Yes	Yes
4	Invasive ductal carcinoma	Grade 3	Female	44	Asian or Pacific Islander	No	No	No	Yes	Yes	Yes
5	Metastatic	Grade 3	Female	48	White	Yes	No	No	Yes	Yes	Yes
6	Invasive ductal carcinoma	Grade 3	Female	70	White	No	No	No	Yes	Yes	Yes
7	Invasive ductal carcinoma	Grade 3	Female	68	Asian or Pacific Islander	No	No	No	Yes	Yes	Yes
8	Invasive ductal carcinoma	Grade 3	Female	32	White	No	No	No	Yes	Yes	Yes

Characteristics of breast-cancer patient-derived xenograft (PDX) samples